CURX logo

CURX
Curanex Pharmaceuticals Inc

398
Mkt Cap
$9.73M
Volume
71,095.00
52W High
$9.18
52W Low
$0.262
PE Ratio
-1.34
CURX Fundamentals
Price
$0.3326
Prev Close
$0.3429
Open
$0.34
50D MA
$0.4137
Beta
1.57
Avg. Volume
108,624.93
EPS (Annual)
-$0.1491
P/B
1.20
$4.74
Loading...
Loading...
News
all
press releases
News Placeholder
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX)
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX) Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of...
PR Newswire
News Placeholder
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX)
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX) Wolf Haldenstein Adler...
PR Newswire
News Placeholder
Rosen Law Firm Encourages Curanex Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation CURX
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX) resulting...
Business Wire
News Placeholder
What's Behind Curanex Pharmaceuticals (CURX) 56% Surge After Hours
Curanex Pharmaceuticals shares surged in after-hours trading after the company completed a GMP-compliant batch supporting its planned IND submission for ulcerative colitis. read more...
Benzinga
<
...
1
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available